PCOS is a hormonal imbalance in women the leads to the formation of ovarian cysts.
Although Polycystic Ovarian Syndrome (PCOS) is one of the
most common endocrine disorders in women, diagnosing it is difficult due to the
wide range of diagnostic criteria used by physicians. PCOS is characterized by
reproductive disorders, skin problems, insulin resistance, high blood pressure,
cholesterol problems, and obesity.
Many of these symptoms are related to metabolic disease. If left untreated,
these health problems can lead to type 2 diabetes, heart disease, cancers, and
infertility.
Supplements for PCOS Control:
- N-actyl cysteine (NAC)
- Casteberry
- Cinnamon
- Quercetin
- Red Yeast
- Curcumin
Recent research has suggested that these symptoms may be
related to high levels of inflammation and oxidative stress in women with PCOS,
with interest in using soy isoflavones in treatment for metabolic disease. Isoflavones are a type of phytoestrogen, a
plant component with estrogenic effects that can protect against hormonal and
metabolic abdnormalities.
One study followed the progress of PCOS suffers who took soy
isoflavones for twelve weeks to compare them to a placebo group. After the study
concluded, the participants who consumed soy isoflavones saw significant
decreases in insulin resistance, hormones statues, triglycerides, and markers
for oxidative stress. Another study saw that Genistein, a soy complex, improved
lipid and hormone profiles in PCOS patients.
Due to the nature of the symptoms associated with PCOS, such
as weight gain or increased facial hair, those who suffer from it tend to
experience a low quality of life.
With a growing number of women seeing metabolic syndrome associated with PCOS,
an effective treatment can increase both quality of life and self-esteem. Treatment
with phytoestrogens such as soy isoflavones may give women a non-invasive,
effective way to improve PCOS symptoms without increasing the burden of harmful
side effects.
Jamilian, M. & Asemi, Z. (2016).
The Effects of Soy Isoflavones on Metabolic Status of Patients With Polycystic
Ovary Syndrome. The Journal Of Clinical Endocrinology & Metabolism,
jc.2016-1762. http://dx.doi.org/10.1210/jc.2016-1762
Khani, B., Mehrabian, F., Khalesi,
E., & Eshraghi, A. (2016). Effect of soy phytoestrogen on metabolic and
hormonal disturbance of women with polycystic ovary syndrome. J Res Med Sci,
16(3), 297-302.
Love, J., McKenzie, J., Nikokavoura,
E., Broom, I., Rolland, C., & Johnston, K. (2016). The experiences of women
with polycystic ovary syndrome on a very low-calorie diet. International Journal
Of Women's Health, Volume 8, 299-310.
http://dx.doi.org/10.2147/ijwh.s100385
No comments:
Post a Comment